Acute Silicosis

Silicosis is a chronic, irreversible occupational lung disease caused by the inhalation of crystalline silica dust (silicon dioxide, SiO2). Silica particles smaller than 10 micrometers penetrate deep into the terminal bronchioles and alveoli, where they are engulfed by alveolar macrophages. However, silica is cytotoxic to macrophages: the sharp, crystalline structure of the particles disrupts lysosomal membranes within the macrophage, releasing proteolytic enzymes and inflammatory mediators (interleukin-1, tumor necrosis factor-alpha, and reactive oxygen species) into the surrounding lung tissue. This triggers a sustained inflammatory response that recruits additional macrophages, lymphocytes, and fibroblasts to the site. The fibroblasts deposit excessive collagen around the silica particles, forming characteristic silicotic nodules -- small, round, well-circumscribed areas of fibrosis typically 2-4 millimeters in diameter. These nodules are most concentrated in the upper lobes and hilar regions. Over time, individual nodules may coalesce into larger masses of fibrosis called progressive massive fibrosis (PMF), which destroys functional lung parenchyma and severely restricts gas exchange. The fibrotic process stiffens the lung tissue, reducing lung compliance and total lung capacity, producing a restrictive pattern on pulmonary function testing. A hallmark radiographic finding is eggshell calcification of the hilar lymph nodes, in which calcium deposits form a ring-like pattern around the periphery of enlarged lymph nodes. Silicosis also significantly increases the risk of tuberculosis because silica impairs macrophage bactericidal function; this combination is termed silicotuberculosis. There are three clinical forms based on exposure intensity and duration: chronic silicosis (develops after 10-30 years of low-level exposure), accelerated silicosis (develops within 5-10 years of moderate exposure), and acute silicosis (develops within weeks to 5 years of intense exposure). Acute silicosis, also called silicoproteinosis, presents with rapid onset of dyspnea and resembles pulmonary alveolar proteinosis, with alveoli filling with proteinaceous fluid rather than forming typical nodules. There is no cure for silicosis; lung damage is permanent and progressive even after exposure ceases.